Immucell (ICCC) Net Margin (2010 - 2026)
Immucell (ICCC) recorded Net Margin of 25.53% in Q2 2026, up 17.74 percentage points from 7.79% a year earlier.
Powered by 
Analysis
Immucell (ICCC) Net Margin (2010 - 2026) Analysis & Trends
On a TTM basis, Immucell's Net Margin came in at -2.44% as of Jun 30, 2026, down 8.67 percentage points year-over-year; for FY2025, it was -3.76%, up 4.38 percentage points from FY2024.
- Annual Net Margin has a five-year change of +2.90 percentage points (FY2020 to FY2025).
- Across earlier years, Net Margin came in at -8.14% in FY2024 (+24.91 pp), -33.05% in FY2023 (-19.62 pp), -13.43% in FY2022 (-13.02 pp) and -0.41% in FY2021 (+6.26 pp).
- The Q2 2026 figure is the highest quarterly Net Margin in data going back to Q2 2010.
- On a year-over-year basis, Net Margin rose in five of the last six quarters, with an average year-over-year change of +8.06 percentage points.
- Peak year-over-year performance for Net Margin in the last five years was a gain of 61.14 percentage points in Q1 2024, against a drop of 84.28 percentage points in Q1 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 30.88% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 21.86% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 21.27% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -8.04% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 22.65% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 16.30% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 23.62% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -134.51% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -1.65% |
| 10 | Immucell | 95.91 Mn | 73.35 Mn | 2.44 Mn | 25.53% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.53% |
| Dec 31, 2025 | -37.36% |
| Sep 30, 2025 | -2.54% |
| Jun 30, 2025 | 7.79% |
| Mar 31, 2025 | 17.94% |
| Dec 31, 2024 | 6.64% |
| Sep 30, 2024 | -11.67% |
| Jun 30, 2024 | -27.99% |
| Mar 31, 2024 | -6.03% |
| Sep 30, 2023 | -17.42% |
| Jun 30, 2023 | -39.06% |
| Mar 31, 2023 | -67.17% |
| Dec 31, 2022 | -42.65% |
| Sep 30, 2022 | -13.66% |
| Jun 30, 2022 | -35.44% |
| Mar 31, 2022 | 17.11% |
| Dec 31, 2021 | 1.36% |
| Sep 30, 2021 | 2.87% |
| Jun 30, 2021 | 3.11% |
| Mar 31, 2021 | -10.74% |
API Access
Immucell Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=ICCC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();